More on ACET
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $4.28 |
|
|||
| Open | $4.22 | ||||
| 52 Wk High | $28.54 | ||||
| 52 Wk Low | $15.69 | ||||
| Day High | $4.29 | ||||
| Day Low | $3.96 | ||||
| P/E | 3.59 | ||||
| EPS | $1.11 | ||||
| Volume | 162,965 | ||||
- Form SCHEDULE 13G Adicet Bio, Inc. Filed by: Zedek Daniel Clayton
- Adicet Bio to Participate in Upcoming Investor Conferences
- Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
- Adicet Bio Inc. (ACET) PT Raised to $34 at H.C. Wainwright
- Adicet Bio Inc. (ACET) PT Raised to $28 at Wedbush
- Form 8-K Adicet Bio, Inc. For: Sep 28
- Adicet Bio reports Phase 1 lupus trial data for prula-cel
- Adicet Bio Announces Positive Safety and Efficacy Data from Prula-cel (formerly ADI-001) Study in Patients with Systemic Lupus Erythematosus with or without Lupus Nephritis
- Adicet Bio to Host Webcast to Present Prula-cel (formerly ADI-001) Clinical Data in Patients with Systemic Lupus Erythematosus with or without Lupus Nephritis
- H.C. Wainwright Reiterates Buy Rating on Adicet Bio Inc. (ACET)
Entities mentioned with ACET
- Earnings | View Related Stories »
- FDA | View Related Stories »
- Definitive Agreement | View Related Stories »
- 13G | View Related Stories »
- Dividend | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Show More...
